Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
82 participants
OBSERVATIONAL
2012-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Material and methods: In this cross-sectional prospective study, the investigators evaulated 82 (19 female, 63 male) patients with a history of umbilical pilonidal disease (e.g. predisposing factors, treatment modalities) between 2012 and 2020.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Surgical Treatment of Pilonidal Sinus Disease
NCT02849197
Effectiveness of Methylene Blue Guidance in Total Excision of Pilonidal Sinus.
NCT01513382
A Single Center Experience in the Management of Pilonidal Disease
NCT05892198
Comparison of Two Different Flap Methods in the Treatment of Pilonidal Sinus Disease
NCT05851690
Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease
NCT01662765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Chi-square tests were conducted to compare the distribution of categorical variables. Age was analyzed as a continuous variable with a t-test. Univariable and multivariable logistic regression models were used to calculate odds ratios and 95% confidence intervals. P-values of less than 0.05 were considered statistically significant. Statistical analyses were conducted with R version of 3.6.1 (R Foundation for Statistical Computing, Vienna, Austria, https://www.r-project.org) software packages.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
surgery
regular surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medeniyet University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arda Isik, MD, FEBS, FACS
assoc.prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ARDA ISIK
Role: PRINCIPAL_INVESTIGATOR
MEDENIYET UNIVERSITY
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
umblicalps
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.